- Home
- KARO vs IMCR Comparison
KARO vs IMCR Comparison
Compare KARO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KARO
- IMCR
- Stock Information
- Founded
- KARO 2001
- IMCR 2008
- Country
- KARO Singapore
- IMCR United Kingdom
- Employees
- KARO N/A
- IMCR N/A
- Industry
- KARO Computer Software: Prepackaged Software
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KARO Technology
- IMCR Health Care
- Exchange
- KARO Nasdaq
- IMCR Nasdaq
- Market Cap
- KARO 1.6B
- IMCR 1.6B
- IPO Year
- KARO 2021
- IMCR 2021
- Fundamental
- Price
- KARO $51.75
- IMCR $32.67
- Analyst Decision
- KARO Buy
- IMCR Buy
- Analyst Count
- KARO 2
- IMCR 10
- Target Price
- KARO $55.50
- IMCR $58.13
- AVG Volume (30 Days)
- KARO 122.7K
- IMCR 446.0K
- Earning Date
- KARO 07-17-2025
- IMCR 08-07-2025
- Dividend Yield
- KARO 2.19%
- IMCR N/A
- EPS Growth
- KARO 24.98
- IMCR N/A
- EPS
- KARO 1.60
- IMCR N/A
- Revenue
- KARO $245,745,961.00
- IMCR $333,581,000.00
- Revenue This Year
- KARO $18.73
- IMCR $26.82
- Revenue Next Year
- KARO $14.86
- IMCR $8.15
- P/E Ratio
- KARO $32.14
- IMCR N/A
- Revenue Growth
- KARO 8.61
- IMCR 25.75
- 52 Week Low
- KARO $28.04
- IMCR $23.15
- 52 Week High
- KARO $63.36
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- KARO 55.53
- IMCR 47.96
- Support Level
- KARO $47.00
- IMCR $30.76
- Resistance Level
- KARO $49.11
- IMCR $33.95
- Average True Range (ATR)
- KARO 1.98
- IMCR 1.35
- MACD
- KARO 0.15
- IMCR -0.12
- Stochastic Oscillator
- KARO 95.55
- IMCR 42.09
About KARO Karooooo Ltd.
Karooooo Ltd is a provider of real-time mobility data analytics solutions for smart transportation. It offers a comprehensive, cloud-based smart mobility platform for connected vehicles and other assets. The company's software-as-a-service platform provides customers with differentiated insights and analytics to optimize business and workforce, increase efficiency and decrease costs, improve safety, monitor environmental impact, assist with regularity compliance, and manage risk. The segments of the group are Cartrack; Carzuka; and Karooooo Logistics, of which key revenue is derived from the Cartrack segment.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.